Clotting factor-Fc chimeric proteins to treat hemophilia

Details for Australian Patent Application No. 2004239244 (hide)

Owner Syntonix Pharmaceuticals, Inc.

Inventors Peters, Robert T.; Bitonti, Alan J.; Rivera, Daniel S.

Agent Cullens

Pub. Number AU-B-2004239244

PCT Pub. Number WO2004/101740

Priority 60/468,837 06.05.03 US

Filing date 6 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 28 January 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/101740 Priority application(s): WO2004/101740

28 January 2010 Application Accepted

  Published as AU-B-2004239244

3 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004239246-Processing of titanium-aluminum-vanadium alloys and products made thereby

2004239235-Multi-layer forming fabrics with packing yarns